Clinical Trials

New Search
Title   A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients With Serious Influenza A Infection
Disease/Condition   Infectious Diseases,Lung Diseases,Influenza
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Paul Riska, MD
Contact Name   Bola Omotosho
Contact Email
IRB/Protocol Number   18-02-315-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Infectious Diseases - Influenza (Flu)